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Monomeric myosin anchoring
 
monomeric myosin first spotted in electron micrographs 
almost 30 years ago has finally been united with a 
proposed function. Tyska and Mooseker (page 395) report 
that myosin-1A associates with and anchors a raft component 
in apical membranes.
Myosin-1A was previously thought to shuttle Golgi-derived 
cargos to the plasma membrane (after most of the distance had 
been covered using microtubule-based motors). But the in vitro 
evidence for this came from undifferentiated cells, and in 
mature, polarized colon epithelial cells, Tyska and Mooseker see 
no evidence of shuttling by myosin-1A. What they did spot was 
cofractionation and cross-linking of myosin-1A with the trans-
membrane disaccharidase sucrase-isomaltase (SI). This raft 
protein is lost from the apical surface when a fragment of either 
myosin-1A or SI interferes with the link between the two full-
length proteins.
Thus, myosin-1A may serve as an anchor, with the 
clustering of SI in rafts helping to secure the link even if 
an individual myosin-1A lets go. The link appears to be 
specific as other raft proteins—which probably come and go 
between different rafts—are not affected by the dominant-
negative constructs. Tyska is now determining whether 
the myosin-1A–SI link is regulated by signaling proteins or 
bacterial toxins.
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Expression of a dominant-negative myosin-1A (green) results 
in loss of apical SI (red).
 
Sensing detachment
 
easing apart the contributions of so many motility 
proteins has proven difficult. So Subauste et al. report 
in this issue that they turned to an all-or-none readout—
apoptotic cell death—to answer some of the same ques-
tions (page 371). They find that the attachment and 
motility protein vinculin pokes its nose between paxillin 
and FAK, thus disrupting signal transduction that activates 
the survival signals sent by extracellular signal–related 
kinase (ERK).
After serum withdrawal, detachment from a substrate, 
or pro-apoptotic drug treatment, cells lacking vinculin 
were compared with wild-type cells. The cells lacking 
vinculin showed greater paxillin–FAK interaction, an 
increase in ERK phosphorylation, and reduced apoptosis.
The reduction in apoptosis (and increase in migration 
rates) could be reversed by ERK pathway inhibitors. 
This is reminiscent of the behavior of many cancer cell 
lines, which lack vinculin and are extremely metastatic 
and motile unless vinculin expression is restored.
Wild-type 
cells may 
survive when 
attached be-
cause of low 
level ERK 
signaling. 
That signal-
ing must be 
repressed 
after detachment, in part via the interfering actions of 
vinculin. Cells lacking vinculin send an excess of the survival 
signal and thus fail to make the correct change in both 
their attachment structures and signaling pathways in 
response to the new nonadherent situation. 
 
 
T
Cells lacking vinculin survive after detachment 
they phosphorylate ERK.
 
A caspase for stress
 
tress in the endoplasmic reticulum 
(ER)—caused by anything from 
ischemia to expression of mutant 
proteins—triggers several responses. 
Cells slow translation, produce more 
chaperones, degrade more unfolded 
proteins, and as a last resort, induce 
apoptosis. Hitomi et al. (page 347) 
identify caspase-4 as a critical compo-
nent of the pathway leading from ER 
stress to apoptosis, specifically after 
the expression of cytotoxic A
 
 
 
 from 
Alzheimer’s patients.
Caspase-12 has already been identified 
as mediating such a function in mice, 
S
 
but the caspase-12 gene in humans has 
frame-shifts and a premature stop codon. 
Hitomi et al. therefore screened cDNA 
libraries with mouse caspase-12 and came 
up with human caspase-4. Although some 
caspase-4 is found on mitochondria, the 
protein is also found on the ER, and its 
cleavage after ER stress or incubation with 
A
 
 
 
 is not prevented by overexpression of 
mitochondrial Bcl-2.
Removal of caspase-4 with siRNA 
halved cell death after ER stress in neuro-
blastoma cells and reduced cell death 
by two thirds after A
 
 
 
 treatment. But the 
incomplete suppression, especially in 
other cell lines, suggests that other cas-
pases may share this responsibility. Sort-
ing out possible contributions by 
caspase-2 and caspase-5 will be important 
before caspase-based therapy is attempted 
for Alzheimer’s. 
 
 
siRNA of caspase-4 (right) prevents most cell 
death after ER stress.
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